What is the ICD-10 code for immunosuppression due to drug therapy?

The primary ICD-10 code for immunosuppression due to drug therapy is D84.821, often used with Z79.899 for long-term drug therapy.

When should T45.1X5A be used?

Use T45.1X5A for adverse effects of drugs when immunosuppression is unintended, such as chemotherapy-induced neutropenia.

ICD-10 Coding for Immunosuppression Due to Drug Therapy(D84.821, D84.8, T45.1X)

Save

Explore comprehensive ICD-10 coding guidelines for immunosuppression due to drug therapy, including primary and ancillary codes, documentation requirements, and common pitfalls.

Also known as:

Drug-induced ImmunodeficiencyImmunosuppressive Drug Therapy

Related ICD-10 Code Ranges

Complete code families applicable to Immunosuppression Due to Drug Therapy

D50-D89Primary Range

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

→

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

Code	Description	When to Use	Key Documentation
D84.821	Immunodeficiency due to drugs	Use when immunosuppression is directly linked to drug therapy.	Lymphocyte subset analysis showing CD4+ < 200 cells/μL Documented history of drug therapy causing immunosuppression
Z79.899	Other long-term (current) drug therapy	Use to document ongoing use of immunosuppressive drugs.	Documentation of long-term use of immunosuppressive drugs
T45.1X5A	Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter	Use when immunosuppression is an unintended adverse effect.	Temporal relationship between drug administration and onset of immunosuppression

Primary ICD-10-CM Codes

Immunodeficiency due to drugs

D84.821Billable

Differential Codes

Alternative codes to consider when ruling out similar conditions

HIV diseaseB20

Documentation & Coding Risks

Avoid these common issues when documenting Immunosuppression Due to Drug Therapy.

Vague documentation of immunosuppression.

Impact

Clinical: Leads to misinterpretation of patient condition., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.

Mitigation

Use structured templates for documentation., Ensure clear linkage between drug and immunosuppression.

Using Z79.899 without D84.821 for immunosuppressive therapy.

Impact

Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient conditions.

Mitigation

Always pair Z79.899 with D84.821 when documenting drug-induced immunosuppression.

Using T45.1X5A for intentional immunosuppression.

Impact

Reimbursement: Potential for incorrect billing and denied claims., Compliance: Violation of coding standards., Data Quality: Misleading data on patient treatment outcomes.

Mitigation

Reserve T45.1X5A for unintended adverse effects only.

Incorrect use of T codes

Impact

Using T codes for intentional immunosuppression.

Mitigation

Educate coders on the distinction between adverse effects and therapeutic use.

Frequently Asked Questions

Documentation requirements, coding pitfalls and FAQs for conditions coded with D84.821.

Primary Code

D84.821

Immunodeficiency due to drugs

Quick Navigation

ICD-10 codes4

Coding risks4

FAQs2

ICD-10 Coding for Immunosuppression Due to Drug Therapy(D84.821, D84.8, T45.1X)

Documentation & Coding Risks

Frequently Asked Questions

What is the ICD-10 code for immunosuppression due to drug therapy?

When should T45.1X5A be used?

Related condition guides